1. Squamoid Eccrine Ductal Carcinoma: Treatment and Outcomes.
- Author
-
Lim MM and Macdonald JA
- Subjects
- Aged, Carcinoma, Ductal pathology, Carcinoma, Ductal surgery, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell surgery, Cheek, Diagnosis, Differential, Humans, Male, Mohs Surgery, Sweat Gland Neoplasms pathology, Sweat Gland Neoplasms surgery, Carcinoma, Ductal diagnosis, Carcinoma, Squamous Cell diagnosis, Eccrine Glands, Sweat Gland Neoplasms diagnosis
- Abstract
Background: Squamoid eccrine ductal carcinoma (SEDC) represents a subtype of eccrine carcinomas that are diagnostically challenging for both clinicians and dermatopathologists., Objective: To provide an updated review of SEDC and examine patient outcomes with different treatment modalities., Methods: A review of Ovid MEDLINE was performed to review the English language medical literature of SEDC., Results: A comprehensive review of clinical presentation, histologic findings, rates of lymphovascular and metastatic disease, treatment modalities and recurrence rates are reviewed., Limitations: There is a limitation on available data because of the rare incidence., Conclusions: SEDC is a rare adnexal neoplasm with a relatively high rate of local recurrence, lymphovascular invasion, perineural invasion, and metastases. Clinicians should be aware of this entity as close follow-up is essential to detect recurrence and metastatic disease. Mohs micrographic surgery seems to result in superior patient outcomes., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF